Drug accelerator Cydan has gained a $34 million injection as it eyes deeper inroads into rare diseases for its second fund.
{iframe}http://www.fiercebiotech.com/biotech/drug-accelerator-cydan-gets-cash-injection-for-genetic-disorders{/iframe}
About BioHealth Innovation
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
Connect
© 2025 BioHealth Innovation.